Raymond L Ownby1, Drenna Waldrop-Valverde2, Adarsh M Kumar3, Deborah Jones3, Benny Fernandez3, Mahendra Kumar3. 1. Department of Psychiatry and Behavioral Medicine, Nova Southeastern University, Fort Lauderdale FL, USA. 2. Nell Hodgson Woodruff College of Medicine, Emory University, Atlanta GA, USA. 3. Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, Miami, FL USA.
Abstract
BACKGROUND: Previous studies have suggested that HIV-1 infection is associated with neuroendocrine abnormalities including alterations in autonomic nervous system (ANS) activity. The norepinephrine (NE) response to cold pressor stress, an α-adrenergic challenge, is blunted in HIV-1 infection. Given the relation of ANS activity to the function of the hypothalamic-pituitary-adrenal (HPA) axis and its role in cognitive functioning, changes in response to stress may be a factor in HIV-related cognitive dysfunction. OBJECTIVE: In this study, we evaluated the NE and cortisol response of persons in three groups. DESIGN/PARTICIPANTS: We studied stress response in three groups: (1) those with HIV-1 infection and a history of injecting drug use (IDU), those with HIV-1 infection but no IDU, and a control group of uninfected individuals without a history of IDU. Stress was induced by administering a neuropsychological test known to induce an immediate increase in NE, the Stroop Color-Word Test. Blood samples were obtained immediately before and after participants completed the Stroop and then at two intervals over the next 20 minutes. Data were analyzed using mixed-effects repeated measures models. MAIN MEASURES: Serum norepinephrine, epinephrine, and cortisol. RESULTS: Analyses showed that those with both HIV-1 infection and history of IDU had a significantly greater NE response to stress that did not return to baseline over 20 minutes compared to those without infection or IDU history. Epinephrine and cortisol responses followed similar patterns, but between-group differences were not statistically significant. CONCLUSIONS: The combination of history of IDU and HIV infection may produce an exaggerated neuroendocrine response that does not quickly return to baseline levels. Given the potential impact of these on cognitive and physical function in affected these individuals, implementing stress management techniques with them may be important.
BACKGROUND: Previous studies have suggested that HIV-1 infection is associated with neuroendocrine abnormalities including alterations in autonomic nervous system (ANS) activity. The norepinephrine (NE) response to cold pressor stress, an α-adrenergic challenge, is blunted in HIV-1 infection. Given the relation of ANS activity to the function of the hypothalamic-pituitary-adrenal (HPA) axis and its role in cognitive functioning, changes in response to stress may be a factor in HIV-related cognitive dysfunction. OBJECTIVE: In this study, we evaluated the NE and cortisol response of persons in three groups. DESIGN/PARTICIPANTS: We studied stress response in three groups: (1) those with HIV-1 infection and a history of injecting drug use (IDU), those with HIV-1 infection but no IDU, and a control group of uninfected individuals without a history of IDU. Stress was induced by administering a neuropsychological test known to induce an immediate increase in NE, the Stroop Color-Word Test. Blood samples were obtained immediately before and after participants completed the Stroop and then at two intervals over the next 20 minutes. Data were analyzed using mixed-effects repeated measures models. MAIN MEASURES: Serum norepinephrine, epinephrine, and cortisol. RESULTS: Analyses showed that those with both HIV-1 infection and history of IDU had a significantly greater NE response to stress that did not return to baseline over 20 minutes compared to those without infection or IDU history. Epinephrine and cortisol responses followed similar patterns, but between-group differences were not statistically significant. CONCLUSIONS: The combination of history of IDU and HIV infection may produce an exaggerated neuroendocrine response that does not quickly return to baseline levels. Given the potential impact of these on cognitive and physical function in affected these individuals, implementing stress management techniques with them may be important.
Authors: E M Martin; L C Robertson; H E Edelstein; W J Jagust; D J Sorensen; D San Giovanni; V A Chirurgi Journal: J Clin Exp Neuropsychol Date: 1992-09 Impact factor: 2.475
Authors: Roger McIntosh; Michael Antoni; Julia Seay; Mary Ann Fletcher; Gail Ironson; Nancy Klimas; Mahendra Kumar; Neil Schneiderman Journal: Behav Sleep Med Date: 2018-02-20 Impact factor: 2.964
Authors: M H Antoni; S Cruess; D G Cruess; M Kumar; S Lutgendorf; G Ironson; E Dettmer; J Williams; N Klimas; M A Fletcher; N Schneiderman Journal: Ann Behav Med Date: 2000
Authors: Vivian P Lara; Paulo Caramelli; Antônio L Teixeira; Maira T Barbosa; Karoline C Carmona; Maria G Carvalho; Ana P Fernandes; Karina B Gomes Journal: Clin Chim Acta Date: 2013-04-20 Impact factor: 3.786
Authors: Gail Ironson; Elizabeth Balbin; Emily Stieren; Kelly Detz; Mary Ann Fletcher; Neil Schneiderman; Mahendra Kumar Journal: Int J Behav Med Date: 2008
Authors: Brian K Lee; Thomas A Glass; Matthew J McAtee; Gary S Wand; Karen Bandeen-Roche; Karen I Bolla; Brian S Schwartz Journal: Arch Gen Psychiatry Date: 2007-07
Authors: Jessica Robinson-Papp; Varuna Astha; Alexandra Nmashie; Sandeep K Sharma; Seunghee Kim-Schulze; Jacinta Murray; Mary Catherine George; Susan Morgello; Bridget R Mueller; Steven A Lawrence; Emma K T Benn Journal: Brain Behav Immun Health Date: 2020-08-03